Clinically researched bladder health formulations

The latest news from Seipel Group

Stay up to date with our news.

Seipel Group receives another Patent

July 2, 2019

The Australian Patent Office has granted us a second patent on Prorox® due to the uniqueness of the formulation. The patent is for the Prevention or Treatment of Benign Prostatic Hyperplasia (BPH) and Related Disorders. We have multiple bladder and prostate patent families, and Urox is currently patented or patent-pending in 25 countries with numerous global trademarks.

Seipel Group Newsletter

Subscribe to our Newsletter for infrequent news, research and formula information.

Seipel Group wins another award!

We’re proud to share that Tracey has won another Australian award for Urox Bladder Control. It is a prestigious Telstra Best of Business Award and

October 24, 2024

Tracey Seipel speaks at Pharmacist Conference

We’ve just returned from a busy Pharmacy Connect Conference in Sydney, where Tracey Seipel’s presentation on the latest CAM treatments options for UTIs and Cystitis

September 10, 2024

We’re a Finalist in 3 Business Awards

More exciting news today, as one of the highest scoring businesses in Australia, we have been selected as a Telstra Best of Business Awards Queensland

September 7, 2024

Why partner with us?

Built for brands. Backed by clinical science.

IP-protected and fully documented.

Human and in vivo trials, peer-reviewed and published.

GMP-certified, low-allergen, and scalable.

Capsules, bottled, powder or bulk ingredient formats.

Custom formulations to reflect your unique brand.

Whether you’re starting fresh or scaling up, we’ll help you explore licensing, review the clinical data, and connect with our expert team.

Seipel Group Pty Ltd
6 Boon Street, Ashgrove, QLD 4060 Australia

Disclaimer and References
*Schoendorfer et al, BMC-CAM, January, 2018. Research funded by the Australian Federal Government and Seipel Group. **Schloss et al, Phytomedicine, 2021. Research funded by the Queensland State Government and Seipel Group. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat cure or prevent any disease. Not recommended during pregnancy. Consult a physician before use if taking medication. Consumers are cautioned to read all labels and follow all directions. You should always consult with your healthcare practitioner before using this or any such product